Steroidogenic capacity of residual ovarian tissue in 4-vinylcyclohexene diepoxide- treated mice

Biology of Reproduction

Volumn 80, Issue 2, 2009, Pages 328-336

  Rivera, Zelieann ^a   Christian, Patricia J ^a   Marion, Sam L ^a   Brooks, Heddwen L ^a   Hoyer, Patricia B ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

4 vinylcyclohexene diepoxide; Aging; Androgenesis; Interstitial cells; Ovarian failure; Ovary; Steroid hormones; Stroma; Theca cells

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; ANDROSTENEDIONE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLOHEXENE DERIVATIVE; FOLLITROPIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; SCAVENGER RECEPTOR BI; STEROID 17ALPHA MONOOXYGENASE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; ANDROSTENEDIONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MENOPAUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY; OVARY FOLLICLE; OVARY INSUFFICIENCY; PRIORITY JOURNAL; STEROIDOGENESIS;

ANDROSTENEDIONE; ANIMALS; CARCINOGENS; CYCLOHEXENES; CYTOCHROME P-450 ENZYME SYSTEM; ESTROUS CYCLE; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GONADAL STEROID HORMONES; HYDROXYSTEROID DEHYDROGENASES; LUTEINIZING HORMONE; MICE; MICE, INBRED C57BL; OVARIAN FAILURE, PREMATURE; OVARY; VINYL COMPOUNDS;

MUS;

EID: 59949096989     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.108.070359     Document Type: Article

References (61)

1. Hirsfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol 1991; 124:43-101.
2. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JCS. Hormone replacement therapy and incidence of Alzheimer's disease in older women: the Cache County Study. JAMA 2002; 288:2123-2129.
3. Liu Y, Ding J, Bush TL, Longenecker JC, Nieto FJ, Golden SH, Szklo M. Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidemiol 2001; 154:489-494.
4. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the U.S. population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436.
5. Compston JE. Sex steroids and bone. Physiol Rev 2001; 81:419-447.
6. Ovarian cancer. Atlanta: American Cancer Society, 2006 (http://documents.cancer.org/114.00/114.00.pdf).
7. Health United States 2006. Washington, D.C.: National Center for Health Statistics, 2006 (http://www.cdc.gov/nchs/data/hus/hus06.pdf).
8. Couzinet B, Meduri G, Lecce MG, Young J, Brailly S, Loosfelt H, Milgrom E, Schaison G. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metabol 2001; 86:50605066.
9. Jabara S, Christenson LK, Wang CY, McAllister JM, Javitt NB, Dunaif A, Strauss JF III. Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metabol 2003; 88:484-492.
10. Havelock JC, Rainey WE, Bradshaw KD, Carr BR. The postmenopausal ovary displays a unique pattern of steroidogenic enzyme expression. Human Reprod 2006; 21:309-317.
11. Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metabol 2007; 92:3040-3043.
12. Mayer LP, Devine PJ, Dyer CA, Hoyer PB. The follicle-deplete ovary produces androgen. Biol Reprod 2004; 71:130-138.
13. Lohff JC, Christian PJ, Marion SL, Arrandale A, Hoyer PB. Characterization of cyclicity and hormonal profile with impending ovarian failure in a novel chemical-induced mouse model of perimenopause. Comp Med 2005; 55:523-527.
14. Lohff JC, Christian PJ, Marion SL, Hoyer PB. Effect of duration of dosing on onset of ovarian failure in a chemical-induced mouse model of perimenopause. Menopause 2006; 13:482-488.
15. Springer LN, McAsey ME, Flaws JA, Tilly JL, Sipes IG, Hoyer PB. Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol Appl Pharmacol 1996; 139:394-401.
16. Hu X, Christian PJ, Thompson KE, Sipes IG, Hoyer PB. Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascade. Biol Reprod 2001; 65:87-93.
17. Hu X, Christian PJ, Sipes IG, Hoyer PB. Expression and redistribution of cellular Bad, Bax, and Bcl-X(L) protein is associated with VCD-induced ovotoxicity in rats. Biol Reprod 2001; 65:1489-1495.
18. Takai Y, Canning J, Perez GI, Pru JK, Schlezinger JJ, Sherr DH, Kolesnick RN, Yuan J, Flavell RA, Korsmeyer SJ, Tilly JL. Bax, caspase- 2, and caspase-3 are required for ovarian follicle loss caused by 4- vinylcyclohexene diepoxide exposure of female mice in vivo. Endocrinology 2003; 144:69-74.
19. Mayer LP, Dyer CA, Eastgard RL, Hoyer PB, Banka CL. Atherosclerotic lesion development in a novel ovary-intact mouse model of perimeno- pause. Arterioscler Thromb Vasc Biol 2005; 25:1910-1916.
20. Keck M, Romero-Aleshire MJ, Cai Q, Hoyer PB, Brooks HL. Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause. Am J Physiol Renal Physiol 2007; 293:F193-F199.
21. Wright LE, Christian PJ, Rivera Z, Van Alstine WG, Funk JL, Bouxsein ML, Hoyer PB. Comparison of skeletal effects of ovariectomy versus chemically-induced ovarian failure in mice. J Bone Miner Res 2008; 23: 1296-1303.
22. Williams JK. A mouse model of the perimenopausal transition: importance for cardiovascular research. Arterioscler Thromb Vasc Biol 2005; 25:1765-1766.
23. Rozen S, Skaletsky H. Primer3 on the WWW for general uses and for biologist programmers. In: Krawetz S, Misener S (eds.), Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press; 2000:365-386.
24. O'Shaughnessy PJ, Willerton L, Baker PJ. Changes in Leydig cell gene expression during development in the mouse. Biol Reprod 2002; 66:966-975.
25. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-410.
26. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389-3402.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-Delta Delta C(T) method. Methods 2001; 25:402-408.
28. Indrapichate K, Meehan D, Lane TA, Chu S-Y, Rao Ch V, Johnson D, Chen TT, Wimalansena J. Biological actions of monoclonal luteinizing hormone/human chorionic gonadotropins receptor antibodies. Biol Reprod 1992; 4:265-278.
29. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics International 2004: 11:36-42.
30. Cannady EA, Dyer CA, Christian PJ, Siper IG, Hoyer PB. Expression and activity of microsomal epoxide hydrolase in follicles isolated from mouse ovaries. Toxicol Sci 2002; 68:24-31.
31. Jones E, DeCherney A. The female reproductive system: menopause. In: Boron W, Boulpaep EL (eds.), Medical Physiology: A Cellular and Molecular Approach, updated edition. Philadelphia, PA: Elsevier Saun- ders, 2005:1163-1165.
32. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 1985; 6:371-399.
33. Magoffin DA. Ovarian theca cell. Int J Biochem Cell Biol 2005; 37:1344-1349.
34. Tilly JL, Kowalski KI, Schomberg DW, Hsueh AJW. Apoptosis in atretic ovarian follicles is associated with selective decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase. Endocrinol 1992; 131:1670-1676.
35. Palumbo A, Yeh J. In situ localization of apoptosis in the rat ovary during follicular atresia. Biol Reprod 1994; 51:888-895.
36. Logothetopoulos J, Dorrington J, Bailey D, Stratis M. Dynamics of follicular growth and atresia of large follicles during the ovarian cycle of the guinea pig: fate of the degenerating follicles, a quantitative study. Anat Rec 1995; 243:37-48.
37. Foghi A, Ravandi A, Teerds KJ, Van Der Donk H, Kuksis A, Dorrington J. Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-ceramide pathway. Endocrinol 1998; 139:2041-2047.
38. Jose M, Puche C, Cabero A, Cabero L, Meseguer A. Expression of P450c17 messenger ribonucleic acid in postmenopausal human ovary tissues. Fertil Steril 1999; 71:528-535.
39. Magoffin DA, Erickson GF. Primary culture of differentiating ovarian androgen-producing cells in defined medium. J Biol Chem 1982; 25: 4507-4513.
40. Wang C, Hsueh AJW, Erickson GF. The role of cyclic AMP in the induction of estrogen and progestin synthesis in cultured granulosa cells. Mol Cell Endocrinol 1982; 25:73-83.
41. Shin SY, Lee JR, Noh GW, Kim HJ, Kang WJ, Kim SH, Chung JK. Analysis of serum levels of antimüllerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein 3, and follicle- stimulating hormone with respect to age and menopausal status. J Korean Med Sci 2008; 23:104-110.
42. Rossmanith WG, Scherbaum WA, Lauritzen C. Gonadotropin secretion during aging in postmenopausal women. Neuroendocrinology 1991; 54: 211-218.
43. Genazzani AD, Petraglia F, Sgarbi L, Montanini V, Hartmann B, Surico N, Biolcati A, Volpe A, Genazzani AR. Difference of LH and FSH secretory characteristics and degree of concordance between postmeno- pausal and aging women. Maturitas 1997; 26:133-138.
44. Teerds KJ, Dorrington JH. Immunohistochemical localization of 3 β-hydroxysteroid dehydrogenase in the rat ovary during follicular development and atresia. Biol Reprod 1993; 49:989-996.
45. Sasano H, Mori T, Sasano N, Nagura H, Mason JI. Immunolocalization of 3β-hydroxysteroid dehydrogenase in human ovary. J Reprod Fertil 1990; 89:743-751.
46. Miller WL, Auchus RJ, Geller DH. The regulation of 17,20-lyase activity. Steroids 1997; 62:133-142.
47. Pandey AV, Miller WL. Regulation of 17,20-lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem 2005; 280: 13265-13271.
48. Souter I, Munir I, Mallick P, Weitsman SR, Geller DH, Magoffin DA.Mutagenesis of putative serine-threonine phosphorylation sites proximal to Arg255 of human cytochrome P450c17 does not selectively promote its 17, 20-lyase activity. Fertil Steril 2006; 85:1290-1299.
49. Pelletier G, Li S, Luu-The V, Tremblay Y, Bélanger A, Labrie F. Immunoelectron microscopic localization of the three key steroidogenic enzymes (cytochrome P450scc, 3β-hydroxysteroid dehydrogenase and cytochrome P450c17) in rat adrenal cortex and gonads. J Endocrinol 2001; 171:373-383.
50. Suzuki T, Sasano H, Tamura M, Aoki H, Fukaya T, Yajima A, Nagura H, Mason JI. Temporal and spatial localization of steroidogenic enzymes in premenopausal human ovaries: in situ hybridization and immunohisto-chemical study. Mol Cell Endocrinol 1993; 97:135-143.
51. Conley AJ, Kaminski MA, Dubowsky SA, Jablonka-Shariff A, Redmer DA, Reynolds LP. Immunohistochemical localization of 3β-hydroxyste- roid dehydrogenase and P450 17α-hydroxylase during follicular and luteal development in pigs, sheep, and cows. Biol Reprod 1995; 52:1081-1094.
52. Dyer CA, Curtiss LK. Apoprotein E-rich high density lipoproteins inhibit rat ovarian androgen synthesis. J Biol Chem 1988; 263:10965-10973.
53. Magoffin DA, Erickson GF. An improved method for primary culture of ovarian androgen-producing cells in serum-free medium: effect of lipoproteins, insulin, and insulin-like growth factor-I. In Vitro Cell Dev Biol 1988; 24:862-870.
54. Williams DL, Connelly M, Temel R, Swarnakar S, Phillips M, de la Llera-Moya M, Rothblat G. Scavenger receptor and cholesterol trafficking. Curr Opin Lipidol 1999; 10:329-339.
55. Azhar S, Reaven E. Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis. Mol Cell Endocrinol 2002; 195:1-26.
56. Krieger M. Charting the fate of the ''good cholesterol'': identification and characterization of the high density lipoprotein receptor SR-BI. Annu Rev Biochem 1999; 68:523-558.
57. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520.
58. Mushayandebvu T, Castracane VD, Gimpel T, Adel T, Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril 1996; 65:721-723.
59. Laughlin GA, Barret-Connor E, Kritz-Silverstein D, von Mühlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000; 85:645-651.
60. Skaba P, Wojtowicz M, Sikora J. Androgen and SHBG serum concentrations in late postmenopause women. Med Sci Monit 2003; 9: CR152-CR156.
61. van Weerden WM, Bierings HG, van Steenbrugge GJ, de Jong FH, Schroder FH. Adrenal glands of mouse and rat do not synthesize androgens. Life Sci 1992; 50:857-861.